rhenium-188-HEDP

DRUG2 trials

Sponsors

Amsterdam UMC, location VUmc, Vrije Universiteit Medisch Centrum

Conditions

Prostate Cancer Metastatic to Bonecastration-resistant prostate carcinoma

Phase 3

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

Amsterdam UMC, location VUmcProstate Cancer Metastatic to Bone

Start: 2018-05-16End: 2024-05-16Target: 402Updated: 2020-11-17

Repeated Rhenium-188-HEDP versus Radium-223-chloride in patients with metastatic castration-resistant prostate cancer: the RARE study.

Active, not recruitingNL-OMON48796

Vrije Universiteit Medisch Centrumcastration-resistant prostate carcinoma

Start: 2018-05-25Target: 402Updated: 2024-02-28

Related Papers

Abstract CT145: Repeated radium-223-chloride versus rhenium-188-HEDP in patients with metastatic castration-resistant prostate cancer: RaRe study

Cancer Research2019-07-012 citations

Abstract CT145: Repeated radium-223-chloride versus rhenium-188-HEDP in patients with metastatic castration-resistant prostate cancer: RaRe study

Clinical Trials2019-07-01